236 related articles for article (PubMed ID: 19738060)
1. NEDD9 promotes oncogenic signaling in mammary tumor development.
Izumchenko E; Singh MK; Plotnikova OV; Tikhmyanova N; Little JL; Serebriiskii IG; Seo S; Kurokawa M; Egleston BL; Klein-Szanto A; Pugacheva EN; Hardy RR; Wolfson M; Connolly DC; Golemis EA
Cancer Res; 2009 Sep; 69(18):7198-206. PubMed ID: 19738060
[TBL] [Abstract][Full Text] [Related]
2. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.
Singh MK; Izumchenko E; Klein-Szanto AJ; Egleston BL; Wolfson M; Golemis EA
Cancer Res; 2010 Nov; 70(21):8907-16. PubMed ID: 20940402
[TBL] [Abstract][Full Text] [Related]
3. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
Little JL; Serzhanova V; Izumchenko E; Egleston BL; Parise E; Klein-Szanto AJ; Loudon G; Shubina M; Seo S; Kurokawa M; Ochs MF; Golemis EA
Oncogene; 2014 Jan; 33(4):411-20. PubMed ID: 23318423
[TBL] [Abstract][Full Text] [Related]
4. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
Paul R; Luo M; Mo X; Lu J; Yeo SK; Guan JL
Breast Cancer Res; 2020 Jun; 22(1):59. PubMed ID: 32493400
[TBL] [Abstract][Full Text] [Related]
5. The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC.
Sima N; Cheng X; Ye F; Ma D; Xie X; Lü W
PLoS One; 2013; 8(9):e74594. PubMed ID: 24058594
[TBL] [Abstract][Full Text] [Related]
6. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
7. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation.
Tikhmyanova N; Golemis EA
PLoS One; 2011; 6(7):e22102. PubMed ID: 21765937
[TBL] [Abstract][Full Text] [Related]
8. Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.
Fan H; Zhao X; Sun S; Luo M; Guan JL
J Biol Chem; 2013 Feb; 288(5):3322-33. PubMed ID: 23255596
[TBL] [Abstract][Full Text] [Related]
9. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
10. NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
Gabbasov R; Xiao F; Howe CG; Bickel LE; O'Brien SW; Benrubi D; Do TV; Zhou Y; Nicolas E; Cai KQ; Litwin S; Seo S; Golemis EA; Connolly DC
Oncogene; 2018 Aug; 37(35):4854-4870. PubMed ID: 29773902
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.
Dai J; Van Wie PG; Fai LY; Kim D; Wang L; Poyil P; Luo J; Zhang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():106-112. PubMed ID: 27664007
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.
Singh M; Cowell L; Seo S; O'Neill G; Golemis E
Cell Biochem Biophys; 2007; 48(1):54-72. PubMed ID: 17703068
[TBL] [Abstract][Full Text] [Related]
14. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
15. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
Shagisultanova E; Gaponova AV; Gabbasov R; Nicolas E; Golemis EA
Gene; 2015 Aug; 567(1):1-11. PubMed ID: 25967390
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Peng M; Ball-Kell SM; Tyner AL
Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
[TBL] [Abstract][Full Text] [Related]
19. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7.
Wang Z; Shen M; Lu P; Li X; Zhu S; Yue S
Oncotarget; 2017 Jan; 8(1):1714-1724. PubMed ID: 27974675
[TBL] [Abstract][Full Text] [Related]
20. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.
Luo M; Fan H; Nagy T; Wei H; Wang C; Liu S; Wicha MS; Guan JL
Cancer Res; 2009 Jan; 69(2):466-74. PubMed ID: 19147559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
